BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38578585)

  • 1. AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ.
    Yoon J; Yang J; Lee HS; Kim MJ; Park VY; Rho M; Yoon JH
    Insights Imaging; 2024 Apr; 15(1):100. PubMed ID: 38578585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.
    Kim G; Mikhael PG; Oseni TO; Bahl M
    Eur Radiol; 2020 Nov; 30(11):6089-6098. PubMed ID: 32591884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
    Miceli R; Gao Y; Qian K; Heller SL
    AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
    [No Abstract]   [Full Text] [Related]  

  • 4. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upgrade Rate of Ductal Carcinoma In Situ to Invasive Carcinoma and the Clinicopathological Factors Predicting the Upgrade Following a Mastectomy: A Retrospective Study.
    Al-Ishaq Z; Hajiesmaeili H; Rahman E; Khosla M; Sircar T
    Cureus; 2023 Mar; 15(3):e35735. PubMed ID: 37016659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Lehman CD; Oseni TO; Bahl M
    Acad Radiol; 2020 Oct; 27(10):1394-1399. PubMed ID: 31699638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging and pathologic features of non-calcified ductal carcinoma in situ: can sonography predict upgrade?
    Komarla R; Gilliland L; Piraner M; Seidel R; Clifford K; Kunjummen J
    Br J Radiol; 2022 Feb; 95(1130):20211013. PubMed ID: 34870448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
    Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
    J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
    Woodard GA; Price ER
    AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depiction of breast cancers on digital mammograms by artificial intelligence-based computer-assisted diagnosis according to cancer characteristics.
    Lee SE; Han K; Yoon JH; Youk JH; Kim EK
    Eur Radiol; 2022 Nov; 32(11):7400-7408. PubMed ID: 35499564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Architectural Distortion on Digital Breast Tomosynthesis With Nonmalignant Pathology at Biopsy.
    Villa-Camacho JC; Bahl M
    AJR Am J Roentgenol; 2022 Jul; 219(1):46-54. PubMed ID: 35107312
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AI-CAD for differentiating lesions presenting as calcifications only on mammography: outcome analysis incorporating the ACR BI-RADS descriptors for calcifications.
    Yoon J; Lee HS; Kim MJ; Park VY; Kim EK; Yoon JH
    Eur Radiol; 2022 Oct; 32(10):6565-6574. PubMed ID: 35748900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Mammography Has Persistently Increased High-Grade and Overall DCIS Detection Without Altering Upgrade Rate.
    Neal CH; Joe AI; Patterson SK; Pujara AC; Helvie MA
    AJR Am J Roentgenol; 2021 Apr; 216(4):912-918. PubMed ID: 33594910
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of invasive breast cancer using shear-wave elastography in patients with biopsy-confirmed ductal carcinoma in situ.
    Bae JS; Chang JM; Lee SH; Shin SU; Moon WK
    Eur Radiol; 2017 Jan; 27(1):7-15. PubMed ID: 27085697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.